SkinCancer360

Why Are Young People Tanning Again? What a New allure Feature Reveals About Melanoma Prevention Challenges
Featured image for “Why Are Young People Tanning Again? What a New allure Feature Reveals About Melanoma Prevention Challenges”

Why Are Young People Tanning Again? What a New allure Feature Reveals About Melanoma Prevention Challenges

June 3, 2026
A recent feature in allure magazine explores a concerning trend: The resurgence of tanning culture among younger generations. The article examines how…
Featured image for “What Patients Should Know About the Rising Rates of Skin Cancer”

What Patients Should Know About the Rising Rates of Skin Cancer

May 22, 2026
Skin cancer is becoming more common, especially among older adults who have spent decades working outdoors, gardening, golfing, walking, driving,…
Featured image for “Skin Cancer in Aging Veterans: Unique Risks & Considerations”

Skin Cancer in Aging Veterans: Unique Risks & Considerations

September 5, 2025
Understanding Skin Cancer in Older Veterans As part of its ongoing webinar series A Closer Look at Skin Cancer, the…
Featured image for “Coping Emotionally After Skin Cancer Surgery”

Coping Emotionally After Skin Cancer Surgery

July 18, 2025
A skin cancer diagnosis often brings with it a clear medical path—surgery, treatment, follow-up. But what’s less discussed is the…
Featured image for “The Cost of Sunscreen May Be Costing Lives”

The Cost of Sunscreen May Be Costing Lives

July 1, 2025
Does Price Influence Sunscreen Use? A Closer Look at the Data The cost of sunscreen could be undermining proper usage,…
Featured image for “Cutaneous Squamous Cell Carcinoma is Exploding Among U.S. Males Over 65”

Cutaneous Squamous Cell Carcinoma is Exploding Among U.S. Males Over 65

June 7, 2025
Males over the age of 65 years are experiencing a tremendous and growing increase in nonmelanoma skin cancers, according to…
Featured image for “Trial Result Confirms the Advantage of Cemiplimab for Skin Cancer at High Risk of Recurrence”

Trial Result Confirms the Advantage of Cemiplimab for Skin Cancer at High Risk of Recurrence

June 3, 2025
Patients with cutaneous squamous cell carcinoma treated with cemiplimab (brand name LIBTAYO) had longer disease-free survival than patients treated with…
Featured image for “What’s New in Clinical Trials for Cutaneous Squamous Cell Carcinoma?”

What’s New in Clinical Trials for Cutaneous Squamous Cell Carcinoma?

May 28, 2025
Q&A with Dr. Neil D. Gross, MD, FACS Dr. Neil D. Gross, M.D., FACS, is a professor, scientist, and surgeon…
Featured image for “Wide Local Excision vs. Mohs Surgery: A Dermatologist Explains”

Wide Local Excision vs. Mohs Surgery: A Dermatologist Explains

April 23, 2025
Introduction Dr. Yaohui (Gloria) Xu, MD, PhD, is a Professor and Section Chief of Mohs Dermatologic Surgery in the Department…
Featured image for “Skin Cancer Risk Persists for 30 Years after Blood Cancer Diagnosis”

Skin Cancer Risk Persists for 30 Years after Blood Cancer Diagnosis

March 31, 2025
Survivors of chronic lymphocytic leukemia and all other blood cancers need to be watchful for the signs of skin cancer,…
[wpb_childpages]

Recent Posts

Featured image for “The FDA Just Approved a New Sunscreen Ingredient— What It Means for Patients with Skin Cancer, Survivors, and the General Public”
Jun. 10, 2026

The FDA Just Approved a New Sunscreen Ingredient— What It Means for Patients with Skin Cancer, Survivors, and the General Public

Featured image for “Why Are Young People Tanning Again? What a New allure Feature Reveals About Melanoma Prevention Challenges”
Jun. 03, 2026

Why Are Young People Tanning Again? What a New allure Feature Reveals About Melanoma Prevention Challenges

Featured image for “What Patients Should Know About the Rising Rates of Skin Cancer”
May. 22, 2026

What Patients Should Know About the Rising Rates of Skin Cancer

Featured image for “SkylineDx to Present Data on Precision Molecular Diagnostics Advances in Cutaneous Squamous Cell Carcinoma at 22nd EADO Congress  ”
Apr. 23, 2026

SkylineDx to Present Data on Precision Molecular Diagnostics Advances in Cutaneous Squamous Cell Carcinoma at 22nd EADO Congress  

Featured image for “Regeneron Announces Approval of Cemiplimab-rwlc for Adjuvant Treatment of Cutaneous Squamous-Cell Carcinoma with a High Risk of Recurrence After Surgery and Radiation    ”
Oct. 08, 2025

Regeneron Announces Approval of Cemiplimab-rwlc for Adjuvant Treatment of Cutaneous Squamous-Cell Carcinoma with a High Risk of Recurrence After Surgery and Radiation    

Post Categories